As I noted in my post on the NICE committee’s recommendation about bosutinib earlier this week, in England the Cancer Drug Fund (CDF) has received a further two years of funding up to the end of March 2016 with a budget of £200 million for each year. please read attached PDF
Media:
cdf_update_102013dr.pdf